Latest news
Fosun Pharma (02196): Levosalbutamol Hydrochloride Nebulizer Solution Receives Marketing Authorization - MoomooMoomoo · Fri, 07 Aug 2026 17:46:44 GMTExpedition raises USD 115m to advance Fosun-sourced DPP1 inhibitor - AllSciAllSci · Wed, 05 Aug 2026 16:05:13 GMTShanghai Fosun Pharmaceutical (Group) Co Ltd Class H (SFOSF) Q4 2023 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Tue, 04 Aug 2026 12:58:57 GMTShanghai Fosun Pharmaceutical (Group) Co Ltd Class H (SFOSF) Q1 2024 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Tue, 04 Aug 2026 12:43:34 GMTFosun Pharma Subsidiary Wins Approval for New Type 2 Diabetes Combination Drug - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 10:26:00 GMTFosun Pharma Units Get Registration Nod for Two Drugs in China - marketscreener.commarketscreener.com · Mon, 03 Aug 2026 11:34:26 GMT